2002:
1992:
1972:
1952:
1942:
1404:
1394:
1384:
40:
1982:
1962:
1414:
1091:
222:
pharmaceutical analysts Viren Mehta and Samuel Isaly founded Mehta & Isaly, a money-management and research firm. This was the predecessor firm to OrbiMed. The firm made its first venture capital investment in 1993.
1872:
1450:
478:
2026:
1945:
1387:
2036:
273:
736:
355:
1443:
384:
851:
1519:
632:
2005:
1436:
1364:
792:
1917:
1268:
766:
657:
581:
447:
793:"Natera Completes $ 54.6 Million Financing to Support Expansion, Continued Global Rollout of Non-Invasive Prenatal Test Panorama™ | Natera, Inc"
968:
910:
1739:
1734:
1642:
1527:
1504:
2041:
1975:
1717:
744:
226:
In 1998, Mehta & Isaly split up into two entities, with Mehta forming Mehta
Partners and Isaly forming OrbiMed Advisors.
1985:
1955:
1965:
1722:
1407:
1242:
199:
1552:
1547:
1542:
1537:
1532:
1230:
413:
607:"AbCellera Closes $ 105 Million Series B Financing to Further Advance World-Leading Antibody Drug Discovery Platform"
1599:
941:
709:
1809:
1759:
1697:
1657:
1604:
1369:
1313:
1032:
903:
293:
606:
1995:
1912:
1907:
1206:
1076:
1216:
1892:
1887:
1842:
1211:
1175:
1036:
852:"TigerText Closes on $ 50 Million in Financing to Accelerate Growth; Launches TigerText Anywhere Initiative"
149:
1594:
1902:
1867:
1764:
1318:
1115:
988:
964:
219:
58:
1819:
1727:
1343:
1001:
973:
954:
329:
278:
244:
In
December 2017, Isaly stepped down from his role as managing partner of OrbiMed due to allegations of
68:
2031:
1847:
1632:
1509:
1397:
1248:
1160:
996:
978:
896:
210:
industries. OrbiMed is considered one of the world's largest dedicated healthcare investment firms.
1922:
1784:
1692:
1687:
1683:
1637:
1417:
1303:
1130:
1105:
1897:
1857:
1794:
1789:
1627:
1328:
1273:
1185:
503:
1862:
1589:
1584:
1579:
1494:
1051:
1027:
1011:
949:
826:
529:
421:
268:
245:
1702:
1571:
1482:
1220:
1155:
263:
238:
116:
108:
554:
1882:
1804:
1652:
1614:
1489:
1463:
1359:
1263:
1253:
1234:
1201:
1125:
1120:
1056:
1041:
138:
818:
479:"Their Hedge Fund's Founder Was Accused of Sexual Harassment. Here's What They Did Next"
1707:
1622:
1499:
1459:
1258:
1238:
1006:
959:
142:
134:
633:"OrbiMed closes its largest VC fund, predicts rebound in healthcare investing in 2014"
2020:
1814:
1799:
1779:
1667:
1428:
1333:
1308:
1298:
1224:
1072:
207:
130:
112:
1927:
1852:
1824:
1769:
1662:
1338:
1293:
1180:
1165:
1046:
308:
39:
1712:
1170:
1110:
1090:
684:"BRIEF-Orbimed Advisors acquired 480,000 common shares of Cynapsus Therapeutics"
683:
283:
17:
1877:
1647:
919:
203:
830:
425:
1774:
1323:
936:
385:"ObriMed Advisors founder to step down, be replaced by management committee"
303:
258:
448:"OrbiMed Seeks $ 4.75 Billion for Fresh Slate of Healthcare-Focused Funds"
230:
555:"Isaly steps down from hedge fund giant OrbiMed after harassment claims"
237:. In 2010, the firm expanded into the Middle East, opening an office in
288:
582:"OrbiMed's Sam Isaly Steps Down Amid Accusations of Sexual Misconduct"
1477:
530:"ORBIMED ADVISORS LLC Profile and Investing Strategy - GuruFocus.com"
298:
234:
767:"Intercept Pharmaceuticals Closes $ 30 Million Series C Financing"
737:"Xconomy: Obesity Startup Gelesis Gobbles Up $ 16M in Financing"
202:. It is focused on making public and private investments in the
120:
1432:
892:
658:"Ambit Biosciences Completes $ 30 Million Series D-2 Financing"
154:
888:
356:"Orbimed drug portfolio balances prognosis with prevention"
198:(OrbiMed Advisors) is an American investment firm based in
881:
229:
In 2007, OrbiMed expanded into Asia, opening offices in
819:"OmniGuide Raises $ 35M in Debt From OrbiMed Advisors"
176:
1833:
1752:
1676:
1613:
1570:
1561:
1518:
1470:
1352:
1286:
1194:
1148:
1139:
1098:
1065:
1020:
987:
935:
926:
171:
161:
148:
126:
104:
92:
74:
64:
54:
46:
274:California Institute for Quantitative Biosciences
2027:Financial services companies established in 1989
710:"DFine raises $ 36.2M to repair spine fractures"
1444:
904:
8:
1946:Private equity and venture capital investors
32:
1388:Alternative investment management companies
1365:Standards Board for Alternative Investments
1981:
1961:
1918:Taxation of private equity and hedge funds
1735:Private investment in public equity (PIPE)
1567:
1451:
1437:
1429:
1413:
1269:Taxation of private equity and hedge funds
1145:
932:
911:
897:
889:
414:"Mehta & Isaly Investment Firm Splits"
38:
31:
2037:Private equity firms of the United States
321:
969:fixed-income relative-value investing
477:McElhaney, Alicia (January 3, 2018).
7:
631:Baum, Stephanie (November 1, 2013).
472:
470:
468:
408:
406:
379:
377:
350:
348:
346:
248:raised by former female employees.
25:
2001:
2000:
1991:
1990:
1980:
1971:
1970:
1960:
1951:
1950:
1941:
1940:
1412:
1403:
1402:
1393:
1392:
1383:
1382:
1089:
817:Hay, Timothy (August 28, 2012).
187:Footnotes / references
1718:Publicly traded private equity
735:Says, Anon (January 3, 2008).
1:
1986:List of venture capital firms
1966:List of private equity firms
1723:Business Development Company
1243:security characteristic line
200:New York City, United States
157:18 billion (March 2024)
1231:Capital asset pricing model
950:Capital structure arbitrage
80:; 26 years ago
2058:
1810:High-net-worth individuals
1600:Leveraged recapitalization
1033:Commodity trading advisors
389:Pensions & Investments
1936:
1698:Limited liability company
1658:Venture capital financing
1605:Dividend recapitalization
1378:
1370:Managed Funds Association
1314:High-net-worth individual
1087:
294:Intercept Pharmaceuticals
185:
37:
1207:Arbitrage pricing theory
27:American investment firm
1765:Institutional investors
1319:Institutional investors
1212:Assets under management
1037:managed futures account
1903:Liquidation preference
1868:Distribution waterfall
1820:Sovereign wealth funds
1344:Sovereign wealth funds
1116:High-frequency trading
965:Fixed income arbitrage
483:Institutional Investor
360:Institutional Investor
2042:Venture capital firms
1976:Venture capital firms
1728:Venture capital trust
1186:Structured securities
1002:Distressed securities
974:Statistical arbitrage
960:Equity market neutral
955:Convertible arbitrage
279:Cynapsus Therapeutics
69:Investment management
1956:Private equity firms
1684:Private equity firms
1633:Post-money valuation
1510:Equity co-investment
1304:Financial endowments
1249:Fundamental analysis
997:Shareholder activism
979:Volatility arbitrage
662:www.businesswire.com
362:. September 22, 2009
33:OrbiMed Advisors LLC
2006:Portfolio companies
1923:Undercapitalization
1775:Insurance companies
1693:Limited partnership
1638:Pre-money valuation
1418:List of hedge funds
1408:Hedge fund managers
1324:Insurance companies
1309:Fund of hedge funds
1217:Black–Scholes model
1131:Proprietary trading
1106:Algorithmic trading
1073:Fund of hedge funds
823:Wall Street Journal
797:investor.natera.com
420:. January 6, 1998.
259:AbCellera Biologics
252:Notable investments
163:Number of employees
34:
1858:Capital commitment
1628:Business incubator
1595:Buy–sell agreement
1274:Technical analysis
771:www.prnewswire.com
580:Norton, Leslie P.
561:. December 8, 2017
504:"OrbiMed Advisors"
418:The New York Times
391:. December 8, 2017
2014:
2013:
1863:Capital structure
1748:
1747:
1590:Divisional buyout
1585:Management buyout
1580:Financial sponsor
1426:
1425:
1282:
1281:
1085:
1084:
1052:Long/short equity
1028:Convergence trade
1012:Special situation
611:www.abcellera.com
534:www.gurufocus.com
510:. October 8, 2014
446:Kreutzer, Laura.
269:Ambit Biosciences
246:sexual harassment
193:
192:
50:Mehta & Isaly
16:(Redirected from
2049:
2004:
2003:
1994:
1993:
1984:
1983:
1974:
1973:
1964:
1963:
1954:
1953:
1944:
1943:
1805:Commercial banks
1795:Investment banks
1703:Carried interest
1568:
1471:Investment types
1453:
1446:
1439:
1430:
1416:
1415:
1406:
1405:
1396:
1395:
1386:
1385:
1329:Investment banks
1176:Foreign exchange
1146:
1093:
933:
913:
906:
899:
890:
885:
884:
882:Official website
867:
866:
864:
862:
848:
842:
841:
839:
837:
814:
808:
807:
805:
803:
789:
783:
782:
780:
778:
763:
757:
756:
754:
752:
747:on June 30, 2008
743:. Archived from
732:
726:
725:
723:
721:
706:
700:
699:
697:
695:
680:
674:
673:
671:
669:
654:
648:
647:
645:
643:
628:
622:
621:
619:
617:
603:
597:
596:
594:
592:
577:
571:
570:
568:
566:
551:
545:
544:
542:
540:
526:
520:
519:
517:
515:
500:
494:
493:
491:
489:
474:
463:
462:
460:
458:
443:
437:
436:
434:
432:
410:
401:
400:
398:
396:
381:
372:
371:
369:
367:
352:
341:
340:
334:
326:
264:Acceleron Pharma
239:Herzliya, Israel
181:
178:
167:112 (March 2024)
109:Citigroup Center
98:Michael Sheffery
88:
86:
81:
42:
35:
21:
18:OrbiMed Advisors
2057:
2056:
2052:
2051:
2050:
2048:
2047:
2046:
2017:
2016:
2015:
2010:
1996:Angel investors
1932:
1883:High-yield debt
1836:financial terms
1835:
1829:
1744:
1672:
1653:Startup company
1609:
1563:
1557:
1514:
1466:
1464:venture capital
1457:
1427:
1422:
1374:
1360:Fund governance
1348:
1278:
1202:Absolute return
1190:
1141:
1135:
1126:Program trading
1121:Prime brokerage
1094:
1081:
1061:
1057:Trend following
1042:Dedicated short
1016:
983:
940:
928:
922:
917:
880:
879:
876:
871:
870:
860:
858:
850:
849:
845:
835:
833:
816:
815:
811:
801:
799:
791:
790:
786:
776:
774:
773:(Press release)
765:
764:
760:
750:
748:
734:
733:
729:
719:
717:
716:. July 16, 2010
708:
707:
703:
693:
691:
682:
681:
677:
667:
665:
664:. June 10, 2011
656:
655:
651:
641:
639:
630:
629:
625:
615:
613:
605:
604:
600:
590:
588:
586:www.barrons.com
579:
578:
574:
564:
562:
553:
552:
548:
538:
536:
528:
527:
523:
513:
511:
502:
501:
497:
487:
485:
476:
475:
466:
456:
454:
445:
444:
440:
430:
428:
412:
411:
404:
394:
392:
383:
382:
375:
365:
363:
354:
353:
344:
332:
328:
327:
323:
318:
313:
254:
216:
189:
175:
164:
141:
139:Venture capital
137:
133:
99:
97:
84:
82:
79:
28:
23:
22:
15:
12:
11:
5:
2055:
2053:
2045:
2044:
2039:
2034:
2029:
2019:
2018:
2012:
2011:
2009:
2008:
1998:
1988:
1978:
1968:
1958:
1948:
1937:
1934:
1933:
1931:
1930:
1925:
1920:
1915:
1910:
1905:
1900:
1895:
1890:
1885:
1880:
1875:
1870:
1865:
1860:
1855:
1850:
1845:
1839:
1837:
1831:
1830:
1828:
1827:
1822:
1817:
1815:Family offices
1812:
1807:
1802:
1800:Merchant banks
1797:
1792:
1787:
1782:
1777:
1772:
1767:
1762:
1756:
1754:
1750:
1749:
1746:
1745:
1743:
1742:
1737:
1732:
1731:
1730:
1725:
1715:
1710:
1708:Management fee
1705:
1700:
1695:
1690:
1680:
1678:
1674:
1673:
1671:
1670:
1665:
1660:
1655:
1650:
1645:
1640:
1635:
1630:
1625:
1623:Angel investor
1619:
1617:
1611:
1610:
1608:
1607:
1602:
1597:
1592:
1587:
1582:
1576:
1574:
1565:
1559:
1558:
1556:
1555:
1550:
1545:
1540:
1535:
1530:
1524:
1522:
1516:
1515:
1513:
1512:
1507:
1502:
1497:
1492:
1487:
1486:
1485:
1474:
1472:
1468:
1467:
1460:Private equity
1458:
1456:
1455:
1448:
1441:
1433:
1424:
1423:
1421:
1420:
1410:
1400:
1390:
1379:
1376:
1375:
1373:
1372:
1367:
1362:
1356:
1354:
1350:
1349:
1347:
1346:
1341:
1336:
1334:Merchant banks
1331:
1326:
1321:
1316:
1311:
1306:
1301:
1299:Family offices
1296:
1290:
1288:
1284:
1283:
1280:
1279:
1277:
1276:
1271:
1266:
1261:
1259:Securitization
1256:
1251:
1246:
1228:
1214:
1209:
1204:
1198:
1196:
1192:
1191:
1189:
1188:
1183:
1178:
1173:
1168:
1163:
1158:
1152:
1150:
1143:
1137:
1136:
1134:
1133:
1128:
1123:
1118:
1113:
1108:
1102:
1100:
1096:
1095:
1088:
1086:
1083:
1082:
1080:
1079:
1069:
1067:
1063:
1062:
1060:
1059:
1054:
1049:
1044:
1039:
1030:
1024:
1022:
1018:
1017:
1015:
1014:
1009:
1007:Risk arbitrage
1004:
999:
993:
991:
985:
984:
982:
981:
976:
971:
962:
957:
952:
946:
944:
942:relative value
930:
924:
923:
918:
916:
915:
908:
901:
893:
887:
886:
875:
874:External links
872:
869:
868:
843:
809:
784:
758:
727:
701:
690:. July 7, 2016
675:
649:
623:
598:
572:
546:
521:
495:
464:
438:
402:
373:
342:
320:
319:
317:
314:
312:
311:
306:
301:
296:
291:
286:
281:
276:
271:
266:
261:
255:
253:
250:
215:
212:
191:
190:
183:
182:
173:
169:
168:
165:
162:
159:
158:
152:
146:
145:
143:Private credit
135:Private equity
128:
124:
123:
106:
102:
101:
94:
90:
89:
76:
72:
71:
66:
62:
61:
56:
52:
51:
48:
44:
43:
26:
24:
14:
13:
10:
9:
6:
4:
3:
2:
2054:
2043:
2040:
2038:
2035:
2033:
2030:
2028:
2025:
2024:
2022:
2007:
1999:
1997:
1989:
1987:
1979:
1977:
1969:
1967:
1959:
1957:
1949:
1947:
1939:
1938:
1935:
1929:
1926:
1924:
1921:
1919:
1916:
1914:
1911:
1909:
1906:
1904:
1901:
1899:
1896:
1894:
1891:
1889:
1886:
1884:
1881:
1879:
1876:
1874:
1871:
1869:
1866:
1864:
1861:
1859:
1856:
1854:
1851:
1849:
1846:
1844:
1841:
1840:
1838:
1832:
1826:
1823:
1821:
1818:
1816:
1813:
1811:
1808:
1806:
1803:
1801:
1798:
1796:
1793:
1791:
1788:
1786:
1783:
1781:
1780:Fund of funds
1778:
1776:
1773:
1771:
1770:Pension funds
1768:
1766:
1763:
1761:
1758:
1757:
1755:
1751:
1741:
1738:
1736:
1733:
1729:
1726:
1724:
1721:
1720:
1719:
1716:
1714:
1711:
1709:
1706:
1704:
1701:
1699:
1696:
1694:
1691:
1689:
1685:
1682:
1681:
1679:
1675:
1669:
1668:Venture round
1666:
1664:
1661:
1659:
1656:
1654:
1651:
1649:
1646:
1644:
1641:
1639:
1636:
1634:
1631:
1629:
1626:
1624:
1621:
1620:
1618:
1616:
1612:
1606:
1603:
1601:
1598:
1596:
1593:
1591:
1588:
1586:
1583:
1581:
1578:
1577:
1575:
1573:
1569:
1566:
1560:
1554:
1551:
1549:
1546:
1544:
1541:
1539:
1536:
1534:
1531:
1529:
1528:Early history
1526:
1525:
1523:
1521:
1517:
1511:
1508:
1506:
1503:
1501:
1498:
1496:
1493:
1491:
1488:
1484:
1481:
1480:
1479:
1476:
1475:
1473:
1469:
1465:
1461:
1454:
1449:
1447:
1442:
1440:
1435:
1434:
1431:
1419:
1411:
1409:
1401:
1399:
1391:
1389:
1381:
1380:
1377:
1371:
1368:
1366:
1363:
1361:
1358:
1357:
1355:
1351:
1345:
1342:
1340:
1339:Pension funds
1337:
1335:
1332:
1330:
1327:
1325:
1322:
1320:
1317:
1315:
1312:
1310:
1307:
1305:
1302:
1300:
1297:
1295:
1294:Vulture funds
1292:
1291:
1289:
1285:
1275:
1272:
1270:
1267:
1265:
1262:
1260:
1257:
1255:
1252:
1250:
1247:
1244:
1240:
1236:
1232:
1229:
1226:
1225:delta neutral
1222:
1218:
1215:
1213:
1210:
1208:
1205:
1203:
1200:
1199:
1197:
1193:
1187:
1184:
1182:
1181:Money markets
1179:
1177:
1174:
1172:
1169:
1167:
1164:
1162:
1159:
1157:
1154:
1153:
1151:
1147:
1144:
1138:
1132:
1129:
1127:
1124:
1122:
1119:
1117:
1114:
1112:
1109:
1107:
1104:
1103:
1101:
1097:
1092:
1078:
1077:Multi-manager
1074:
1071:
1070:
1068:
1064:
1058:
1055:
1053:
1050:
1048:
1045:
1043:
1040:
1038:
1034:
1031:
1029:
1026:
1025:
1023:
1019:
1013:
1010:
1008:
1005:
1003:
1000:
998:
995:
994:
992:
990:
986:
980:
977:
975:
972:
970:
966:
963:
961:
958:
956:
953:
951:
948:
947:
945:
943:
938:
934:
931:
925:
921:
914:
909:
907:
902:
900:
895:
894:
891:
883:
878:
877:
873:
857:
853:
847:
844:
832:
828:
824:
820:
813:
810:
798:
794:
788:
785:
772:
768:
762:
759:
746:
742:
738:
731:
728:
715:
711:
705:
702:
689:
685:
679:
676:
663:
659:
653:
650:
638:
634:
627:
624:
612:
608:
602:
599:
587:
583:
576:
573:
560:
556:
550:
547:
535:
531:
525:
522:
509:
508:FierceBiotech
505:
499:
496:
484:
480:
473:
471:
469:
465:
453:
449:
442:
439:
427:
423:
419:
415:
409:
407:
403:
390:
386:
380:
378:
374:
361:
357:
351:
349:
347:
343:
338:
331:
325:
322:
315:
310:
307:
305:
302:
300:
297:
295:
292:
290:
287:
285:
282:
280:
277:
275:
272:
270:
267:
265:
262:
260:
257:
256:
251:
249:
247:
242:
240:
236:
232:
227:
224:
221:
213:
211:
209:
208:Biotechnology
205:
201:
197:
188:
184:
180:
174:
170:
166:
160:
156:
153:
151:
147:
144:
140:
136:
132:
131:Public equity
129:
125:
122:
118:
114:
113:New York City
110:
107:
103:
95:
91:
77:
73:
70:
67:
63:
60:
57:
53:
49:
45:
41:
36:
30:
19:
1928:Vintage year
1853:Capital call
1825:Crowdfunding
1760:Corporations
1663:Venture debt
1171:Fixed income
1047:Global macro
989:Event-driven
859:. Retrieved
856:TigerConnect
855:
846:
834:. Retrieved
822:
812:
800:. Retrieved
796:
787:
775:. Retrieved
770:
761:
749:. Retrieved
745:the original
740:
730:
718:. Retrieved
713:
704:
692:. Retrieved
687:
678:
666:. Retrieved
661:
652:
640:. Retrieved
637:MedCity News
636:
626:
614:. Retrieved
610:
601:
589:. Retrieved
585:
575:
563:. Retrieved
558:
549:
537:. Retrieved
533:
524:
512:. Retrieved
507:
498:
486:. Retrieved
482:
455:. Retrieved
451:
441:
429:. Retrieved
417:
393:. Retrieved
388:
364:. Retrieved
359:
336:
324:
309:TigerConnect
243:
228:
225:
217:
195:
194:
186:
105:Headquarters
100:Arvind Desai
96:Samuel Isaly
55:Company type
29:
2032:Hedge funds
1790:Foundations
1713:Pledge fund
1505:Secondaries
1398:Hedge funds
1161:Derivatives
1156:Commodities
1111:Day trading
1021:Directional
920:Hedge funds
714:VentureBeat
284:DFINE, Inc.
220:S.G Warburg
2021:Categories
1878:Envy ratio
1785:Endowments
1648:Seed money
1562:Terms and
1353:Governance
927:Investment
330:"Form ADV"
316:References
214:Background
204:Healthcare
1848:Cap table
1753:Investors
1677:Structure
1495:Mezzanine
1483:Leveraged
1287:Investors
937:Arbitrage
831:0099-9660
426:0362-4331
304:OmniGuide
218:In 1989,
1898:Leverage
1834:Related
1564:concepts
929:strategy
488:July 15,
457:July 15,
366:July 15,
231:Shanghai
127:Products
117:New York
65:Industry
47:Formerly
1908:M&A
1615:Venture
1520:History
1490:Venture
1149:Markets
1140:Related
1099:Trading
861:May 22,
836:May 22,
802:May 22,
777:May 22,
751:May 22,
741:Xconomy
720:May 22,
694:May 22,
688:Reuters
668:May 22,
642:May 22,
616:May 22,
591:May 22,
565:May 22,
539:May 22,
514:May 22,
431:May 22,
395:May 22,
289:Gelesis
196:OrbiMed
177:orbimed
172:Website
93:Founder
83: (
75:Founded
59:Private
1873:EBITDA
1572:Buyout
1500:Growth
1478:Buyout
1221:Greeks
1166:Equity
829:
424:
299:Natera
235:Mumbai
1688:funds
1553:2020s
1548:2010s
1543:2000s
1538:1990s
1533:1980s
1264:Short
1254:Hedge
1235:alpha
1142:terms
1066:Other
333:(PDF)
1740:SPAC
1686:and
1643:SAFE
1462:and
1239:beta
1195:Misc
863:2021
838:2021
827:ISSN
804:2021
779:2021
753:2021
722:2021
696:2021
670:2021
644:2021
618:2021
593:2021
567:2021
559:STAT
541:2021
516:2021
490:2023
459:2023
433:2021
422:ISSN
397:2021
368:2023
233:and
206:and
179:.com
155:US$
121:U.S.
85:1998
78:1998
1913:PME
1893:IRR
1888:IPO
1843:AUM
452:WSJ
337:SEC
150:AUM
2023::
1241:/
1237:/
1223::
1075:/
1035:/
967:/
854:.
825:.
821:.
795:.
769:.
739:.
712:.
686:.
660:.
635:.
609:.
584:.
557:.
532:.
506:.
481:.
467:^
450:.
416:.
405:^
387:.
376:^
358:.
345:^
335:.
241:.
119:,
115:,
111:,
1452:e
1445:t
1438:v
1245:)
1233:(
1227:)
1219:(
939:/
912:e
905:t
898:v
865:.
840:.
806:.
781:.
755:.
724:.
698:.
672:.
646:.
620:.
595:.
569:.
543:.
518:.
492:.
461:.
435:.
399:.
370:.
339:.
87:)
20:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
